Dabigatran in the treatment of recurrent deep vein thrombosis and pulmonary embolism

Abstract

Availability of new direct anticoagulants has led to significant advances in the prevention and therapy of venous embolism. Dabigatran etexilate is a typical representative of the group of direct oral anticoagulants, and its efficacy has been shown in controlled clinical trials in the indications of both treatment and prevention of deep vein thrombosis and treatment and prevention of pulmonary embolism.

Keywords

• Dabigatran etexilate
• vein thrombosis